How should hyperbilirubinemia be considered in the definition of the hearing screening protocol for neonates at risk?

Alvarenga KF, Campelo APDDS, Rays MS, Amorim AAL, Araújo ES, Jacob LCB

Open source

DOI
10.1590/2317-1782/20232022273pt
Published
2024
Container
CoDAS
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1590/2317-1782/20232022273pt,
  title = {How should hyperbilirubinemia be considered in the definition of the hearing screening protocol for neonates at risk?},
  author = {Alvarenga KF and Campelo APDDS and Rays MS and Amorim AAL and Araújo ES and Jacob LCB},
  year = {2024},
  journal = {CoDAS},
  doi = {10.1590/2317-1782/20232022273pt},
  url = {https://doi.org/10.1590/2317-1782/20232022273pt}
}

RIS

TY  - JOUR
TI  - How should hyperbilirubinemia be considered in the definition of the hearing screening protocol for neonates at risk?
AU  - Alvarenga KF
AU  - Campelo APDDS
AU  - Rays MS
AU  - Amorim AAL
AU  - Araújo ES
AU  - Jacob LCB
PY  - 2024
JO  - CoDAS
DO  - 10.1590/2317-1782/20232022273pt
UR  - https://doi.org/10.1590/2317-1782/20232022273pt
ER  - 

APA

KF, A., APDDS, C., MS, R., AAL, A., ES, A., & LCB, J. (2024). How should hyperbilirubinemia be considered in the definition of the hearing screening protocol for neonates at risk?. CoDAS. https://doi.org/10.1590/2317-1782/20232022273pt

Source records